Not investment advice. Educational platform. See Disclaimer.
AMEX: CYBN
Cybin Inc.
Healthcare | Biotechnology
$8.28as of 2026-08-26 08:03 UTC
Volume716.5K
EPS (TTM)$-2.15
Cybin Inc. (AMEX: CYBN) is a biotechnology company trading at $8.28. Figures from SEC EDGAR and market feeds; updated 2026-08-26 08:03 UTC.
52-Week Range
Low $8.28High $8.28
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Cybin Inc. is a biotechnology company, listed on AMEX as CYBN.
What is CYBN's valuation?
CYBN trades at $8.28, as of 2026-08-26.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-08-26 08:03 UTC. This page is also available as JSON at /api/data?ticker=CYBN and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for CYBN and 5,000+ tickers.